Below are the top 10 U.S.-listed Chinese stocks with highest upside potential, UPDATED TODAY before 4:30 AM ET, based on the difference between current price and Wall Street analysts' average target price.
China Education Alliance, Inc. (NYSE:CEU) has the 1st highest upside potential in this segment of the market. Its upside is 260.2%. Its consensus target price is $8.50 based on the average of all estimates. SkyPeople Fruit Juice, Inc. (NASDAQ:SPU) has the 2nd highest upside potential in this segment of the market. Its upside is 218.6%. Its consensus target price is $13.00 based on the average of all estimates. NF Energy Saving Corp (NASDAQ:NFEC) has the 3rd highest upside potential in this segment of the market. Its upside is 211.7%. Its consensus target price is $12.50 based on the average of all estimates. NIVS IntelliMedia Technology Group Inc (NYSE:NIV) has the 4th highest upside potential in this segment of the market. Its upside is 203.0%. Its consensus target price is $7.00 based on the average of all estimates. WSP Holdings Limited (NYSE:WH) has the 5th highest upside potential in this segment of the market. Its upside is 185.7%. Its consensus target price is $3.00 based on the average of all estimates.
Xinyuan Real Estate Co., Ltd. (ADR) (NYSE:XIN) has the 6th highest upside potential in this segment of the market. Its upside is 175.5%. Its consensus target price is $6.67 based on the average of all estimates. China Ritar Power Corp. (NASDAQ:CRTP) has the 7th highest upside potential in this segment of the market. Its upside is 163.5%. Its consensus target price is $6.67 based on the average of all estimates. Sutor Technology Group Ltd. (NASDAQ:SUTR) has the 8th highest upside potential in this segment of the market. Its upside is 157.7%. Its consensus target price is $5.00 based on the average of all estimates. China TransInfo Technology Corp. (NASDAQ:CTFO) has the 9th highest upside potential in this segment of the market. Its upside is 151.1%. Its consensus target price is $11.00 based on the average of all estimates. China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) has the 10th highest upside potential in this segment of the market. Its upside is 147.0%. Its consensus target price is $8.25 based on the average of all estimates.
Negocioenlinea
tdp2664
China Analyst
Top 10 U.S.-Listed Chinese Stocks with Highest Upside: CEU, SPU, NFEC, NIV, WH, XIN, CRTP, SUTR, CTFO, NKBP (Dec 17, 2010)
No comments:
Post a Comment